Allergan Current Ratio 2006-2018 | AGN

Current and historical current ratio for Allergan (AGN) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Allergan current ratio for the three months ending September 30, 2018 was 0.92.
Allergan Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $5.74B $6.23B 0.92
2018-06-30 $6.10B $6.13B 1.00
2018-03-31 $6.39B $5.82B 1.10
2017-12-31 $11.38B $9.85B 1.16
2017-09-30 $10.11B $8.56B 1.18
2017-06-30 $10.43B $8.64B 1.21
2017-03-31 $13.70B $10.39B 1.32
2016-12-31 $17.86B $7.88B 2.27
2016-09-30 $31.72B $8.03B 3.95
2016-06-30 $8.76B $8.87B 0.99
2016-03-31 $10.09B $10.20B 0.99
2015-12-31 $8.58B $8.29B 1.04
2015-09-30 $16.66B $8.13B 2.05
2015-06-30 $10.49B $7.65B 1.37
2015-03-31 $11.02B $7.66B 1.44
2014-12-31 $7.11B $5.25B 1.36
2014-09-30 $6.25B $4.48B 1.40
2014-06-30 $8.27B $4.18B 1.98
2014-03-31 $4.54B $3.00B 1.51
2013-12-31 $4.44B $3.30B 1.35
2013-09-30 $4.07B $2.81B 1.45
2013-06-30 $3.92B $2.39B 1.64
2013-03-31 $3.84B $2.94B 1.31
2012-12-31 $3.84B $2.75B 1.40
2012-09-30 $2.44B $1.56B 1.57
2012-06-30 $2.32B $1.53B 1.52
2012-03-31 $2.41B $1.58B 1.53
2011-12-31 $2.57B $1.84B 1.40
2011-09-30 $1.84B $1.02B 1.81
2011-06-30 $2.01B $1.37B 1.47
2011-03-31 $1.94B $0.86B 2.26
2010-12-31 $1.79B $0.81B 2.21
2010-09-30 $1.76B $0.75B 2.34
2010-06-30 $1.76B $0.75B 2.33
2010-03-31 $1.77B $0.88B 2.01
2009-12-31 $1.77B $1.05B 1.69
2009-09-30 $1.89B $0.44B 4.29
2009-06-30 $1.69B $1.19B 1.42
2009-03-31 $1.56B $1.14B 1.37
2008-12-31 $1.46B $0.48B 3.03
2008-09-30 $1.32B $0.40B 3.32
2008-06-30 $1.25B $0.43B 2.93
2008-03-31 $1.16B $0.44B 2.67
2007-12-31 $1.17B $0.45B 2.64
2007-09-30 $1.12B $0.40B 2.85
2007-06-30 $1.10B $0.46B 2.38
2007-03-31 $1.10B $0.45B 2.44
2006-12-31 $1.26B $0.69B 1.83
2006-09-30 $1.62B $0.35B 4.64
2006-06-30 $1.57B $0.38B 4.13
2006-03-31 $1.43B $0.31B 4.66
2005-12-31 $1.35B $0.25B 5.51
2005-09-30 $1.31B $0.25B 5.31
2005-06-30 $1.32B $0.24B 5.50
2005-03-31 $1.37B $0.24B 5.69
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $53.085B $15.941B
Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $22.626B 6.93
Mylan (MYL) United Kingdom $18.006B 7.41
Bausch Health Cos (BHC) Canada $8.859B 6.41
Dr Reddy's Laboratories (RDY) India $5.791B 23.13
Mallinckrodt Public Limited Company (MNK) United Kingdom $2.571B 4.29
Supernus Pharmaceuticals (SUPN) United States $2.296B 21.75
Amphastar Pharmaceuticals (AMPH) United States $0.953B 103.35
Akorn (AKRX) United States $0.860B 0.00
Homology Medicines (FIXX) United States $0.769B 0.00
Assembly Biosciences (ASMB) United States $0.628B 0.00
CymaBay Therapeutics (CBAY) United States $0.574B 0.00
Corium (CORI) United States $0.459B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.455B 0.00
Voyager Therapeutics (VYGR) United States $0.405B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.296B 0.00
Teligent (TLGT) United States $0.137B 0.00
Sol-Gel Technologies (SLGL) Israel $0.132B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.093B 0.00
Aevi Genomic Medicine (GNMX) United States $0.071B 0.00
Acasti Pharma (ACST) Canada $0.057B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.051B 0.00
Evoke Pharma (EVOK) United States $0.042B 0.00
Agile Therapeutics (AGRX) United States $0.029B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.008B 0.00